{
  "id": "domain-3-ch07-trauma-stressor",
  "name": "Ch 7: Trauma- and Stressor-Related Disorders",
  "domain": "Domain 3: Clinical Psychopathology",
  "questions": [
    {
      "type": "single-choice",
      "id": "d3-tds-001",
      "stem": "A combat veteran presents 4 months after returning from deployment with intrusive memories, nightmares, avoidance of war-related stimuli, emotional numbing, hypervigilance, and exaggerated startle. He also reports feeling detached from his body during stressful moments. According to DSM-5, what is the appropriate diagnosis and specifier?",
      "options": [
        "Acute stress disorder",
        "PTSD with dissociative symptoms",
        "PTSD without specifier",
        "Adjustment disorder with anxiety"
      ],
      "correctAnswer": 1,
      "explanation": "Duration >1 month (4 months) rules out acute stress disorder (<1 month). He meets PTSD criteria across clusters (intrusions, avoidance, cognition/mood changes, arousal/reactivity changes). His depersonalization (detached from body) indicates the dissociative subtype specifier should be applied. This subtype has treatment implications (may respond to different approaches).",
      "difficulty": "hard",
      "tags": [
        "PTSD",
        "dissociative subtype",
        "DSM-5 specifiers"
      ]
    },
    {
      "type": "single-choice",
      "id": "d3-tds-004",
      "stem": "Research on the neurobiology of PTSD has most consistently demonstrated which finding?",
      "options": [
        "Increased hippocampal volume",
        "Decreased amygdala activation to threat",
        "Reduced prefrontal cortex regulation of amygdala",
        "Elevated cortisol levels"
      ],
      "correctAnswer": 2,
      "explanation": "PTSD neurobiology consistently shows: reduced prefrontal cortex (especially vmPFC) regulation of amygdala activity, leading to heightened threat responses and poor fear extinction. Additionally, DECREASED (not increased) hippocampal volume and INCREASED amygdala reactivity are found. Cortisol findings are paradoxically LOW in PTSD despite chronic stress (HPA axis dysregulation).",
      "difficulty": "hard",
      "tags": [
        "PTSD neurobiology",
        "prefrontal cortex",
        "amygdala"
      ]
    },
    {
      "type": "single-choice",
      "id": "d3-tds-005",
      "stem": "Which therapeutic approach has the strongest evidence base for PTSD according to major treatment guidelines?",
      "options": [
        "Supportive psychotherapy",
        "Psychodynamic psychotherapy",
        "Trauma-focused CBT (including PE and CPT)",
        "EMDR without cognitive component"
      ],
      "correctAnswer": 2,
      "explanation": "Major guidelines (APA, VA/DoD, NICE, ISTSS) identify trauma-focused CBT approaches—specifically Prolonged Exposure (PE) and Cognitive Processing Therapy (CPT)—as having the strongest evidence for PTSD. EMDR also has strong support and is recommended, typically equal to trauma-focused CBT. Supportive and psychodynamic therapies have less evidence for PTSD specifically.",
      "difficulty": "hard",
      "tags": [
        "PTSD treatment",
        "evidence-based",
        "trauma-focused CBT"
      ]
    },
    {
      "type": "multiple-choice",
      "id": "d3-tds-006",
      "stem": "Which are DSM-5 symptom clusters for PTSD? (Select all that apply)",
      "options": [
        "Intrusion symptoms (re-experiencing)",
        "Avoidance of trauma-related stimuli",
        "Negative alterations in cognitions and mood",
        "Depersonalization and derealization",
        "Alterations in arousal and reactivity"
      ],
      "correctAnswers": [
        0,
        1,
        2,
        4
      ],
      "explanation": "DSM-5 PTSD has four symptom clusters: B (Intrusion/re-experiencing), C (Avoidance), D (Negative cognitions and mood—NEW in DSM-5, split from avoidance), E (Arousal and reactivity). Depersonalization/derealization is a SPECIFIER for a subtype, not a required cluster. DSM-IV had three clusters; DSM-5 expanded to four.",
      "difficulty": "hard",
      "tags": [
        "PTSD",
        "DSM-5 criteria",
        "symptom clusters"
      ]
    },
    {
      "type": "multiple-choice",
      "id": "d3-tds-008",
      "stem": "Which medications have FDA approval for treatment of PTSD? (Select all that apply)",
      "options": [
        "Sertraline",
        "Paroxetine",
        "Prazosin",
        "Propranolol",
        "Venlafaxine"
      ],
      "correctAnswers": [
        0,
        1
      ],
      "explanation": "Only sertraline and paroxetine (both SSRIs) have FDA approval for PTSD. Prazosin has evidence for PTSD nightmares but no FDA approval. Propranolol has been studied for prevention but lacks approval. Venlafaxine has evidence and guideline recommendations but no FDA approval. Other SSRIs/SNRIs are used off-label based on evidence.",
      "difficulty": "hard",
      "tags": [
        "PTSD pharmacotherapy",
        "FDA-approved",
        "SSRIs"
      ]
    },
    {
      "type": "multiple-choice",
      "id": "d3-tds-009",
      "stem": "Which features are required for a DSM-5 diagnosis of reactive attachment disorder? (Select all that apply)",
      "options": [
        "Pattern of inhibited, emotionally withdrawn behavior toward caregivers",
        "Persistent social and emotional disturbance",
        "History of insufficient care (neglect, deprivation, or institutional rearing)",
        "Onset before age 5",
        "Developmental age of at least 9 months"
      ],
      "correctAnswers": [
        0,
        1,
        2,
        3,
        4
      ],
      "explanation": "RAD criteria: (A) inhibited/withdrawn behavior toward caregivers—rarely seeks or responds to comfort, (B) social/emotional disturbance (minimal responsiveness, limited positive affect, unexplained irritability/sadness), (C) history of insufficient care, (D) care presumed responsible for disturbed behavior, (E) doesn't meet ASD criteria, (F) symptoms before age 5, (G) developmental age ≥9 months.",
      "difficulty": "hard",
      "tags": [
        "reactive attachment disorder",
        "DSM-5 criteria",
        "childhood trauma"
      ]
    },
    {
      "type": "matrix-single",
      "id": "d3-tds-011",
      "stem": "Match each trauma/stressor-related disorder with its duration criterion.",
      "rows": [
        "Acute stress disorder",
        "PTSD",
        "Adjustment disorder"
      ],
      "columns": [
        "3 days to 1 month post-trauma",
        "Greater than 1 month post-trauma",
        "Within 3 months of stressor onset"
      ],
      "correctAnswers": {
        "Acute stress disorder": "3 days to 1 month post-trauma",
        "PTSD": "Greater than 1 month post-trauma",
        "Adjustment disorder": "Within 3 months of stressor onset"
      },
      "explanation": "Duration distinguishes these disorders: ASD = 3 days to 1 month after trauma. PTSD = symptoms >1 month after trauma (though onset may be delayed). Adjustment disorder = symptoms begin within 3 months of stressor and don't persist >6 months after stressor ends. ASD can progress to PTSD if symptoms continue past 1 month.",
      "difficulty": "hard",
      "tags": [
        "trauma disorders",
        "duration criteria",
        "differential diagnosis"
      ]
    },
    {
      "type": "matrix-single",
      "id": "d3-tds-012",
      "stem": "Match each evidence-based PTSD treatment with its primary mechanism.",
      "rows": [
        "Prolonged Exposure (PE)",
        "Cognitive Processing Therapy (CPT)",
        "EMDR"
      ],
      "columns": [
        "Imaginal and in-vivo exposure to extinguish fear",
        "Challenging trauma-related cognitions",
        "Bilateral stimulation during trauma processing"
      ],
      "correctAnswers": {
        "Prolonged Exposure (PE)": "Imaginal and in-vivo exposure to extinguish fear",
        "Cognitive Processing Therapy (CPT)": "Challenging trauma-related cognitions",
        "EMDR": "Bilateral stimulation during trauma processing"
      },
      "explanation": "PE uses imaginal exposure (revisiting trauma memory) and in-vivo exposure (approaching avoided situations) based on emotional processing theory. CPT focuses on identifying and challenging 'stuck points' (maladaptive trauma-related beliefs). EMDR uses bilateral stimulation (eye movements, tapping) while processing trauma memories. All three are empirically supported.",
      "difficulty": "hard",
      "tags": [
        "PTSD treatment",
        "mechanisms",
        "evidence-based treatments"
      ]
    },
    {
      "type": "cloze-dropdown",
      "id": "d3-tds-015",
      "stem": "A patient describes an event 3 weeks ago where she believed she was going to die. Since then, she has had intrusive memories, avoidance, negative mood, and hyperarousal. She reports feeling like she is watching herself from outside her body. The appropriate diagnosis is [[1]] because [[2]]. The specifier to apply is [[3]].",
      "options": {
        "1": [
          "Acute stress disorder",
          "PTSD",
          "Adjustment disorder",
          "Brief psychotic disorder"
        ],
        "2": [
          "Duration is less than 1 month",
          "She has all four PTSD symptom clusters",
          "The trauma was life-threatening",
          "She has dissociative symptoms"
        ],
        "3": [
          "With dissociative symptoms",
          "With delayed expression",
          "With panic attacks",
          "No specifier applicable for ASD"
        ]
      },
      "correctAnswers": {
        "1": "Acute stress disorder",
        "2": "Duration is less than 1 month",
        "3": "No specifier applicable for ASD"
      },
      "explanation": "At 3 weeks post-trauma (3 days to 1 month), this is ASD, not PTSD. While she has what would be PTSD symptoms, the duration criterion determines the diagnosis. Importantly, ASD does not have a dissociative specifier like PTSD does—dissociative symptoms are part of the ASD criteria themselves (DSM-5 includes them in the 9 required symptoms).",
      "difficulty": "hard",
      "tags": [
        "acute stress disorder",
        "PTSD",
        "duration criteria"
      ]
    },
    {
      "type": "bowtie",
      "id": "d3-tds-017",
      "stem": "A 30-year-old woman presents after a sexual assault that occurred 3 months ago. She has intrusive memories and nightmares of the assault, avoids any reminders, feels emotionally numb, has lost interest in activities, has difficulty sleeping, and is hypervigilant. She also reports persistent beliefs that the world is completely dangerous and she is permanently damaged.",
      "centerStatement": "Primary diagnosis",
      "leftColumn": {
        "header": "Criterion B, C, D, E Symptoms",
        "options": [
          "Intrusion: memories and nightmares (Criterion B)",
          "Avoidance: avoiding reminders (Criterion C)",
          "Cognitions/mood: negative beliefs, numbing, lost interest (Criterion D)",
          "Arousal: sleep problems, hypervigilance (Criterion E)"
        ]
      },
      "rightColumn": {
        "header": "Evidence-Based Treatment Options",
        "options": [
          "Prolonged Exposure therapy",
          "Cognitive Processing Therapy",
          "SSRI (sertraline or paroxetine)",
          "Benzodiazepine monotherapy"
        ]
      },
      "correctAnswers": {
        "center": "PTSD",
        "left": [
          "Intrusion: memories and nightmares (Criterion B)",
          "Avoidance: avoiding reminders (Criterion C)",
          "Cognitions/mood: negative beliefs, numbing, lost interest (Criterion D)",
          "Arousal: sleep problems, hypervigilance (Criterion E)"
        ],
        "right": [
          "Prolonged Exposure therapy",
          "Cognitive Processing Therapy",
          "SSRI (sertraline or paroxetine)"
        ]
      },
      "explanation": "All four PTSD symptom clusters are present 3 months post-trauma, meeting PTSD criteria. Evidence-based treatments: PE (exposure-based), CPT (cognitive restructuring of stuck points like 'world is dangerous'), and FDA-approved SSRIs. Benzodiazepines are NOT recommended for PTSD—evidence suggests they may interfere with fear extinction and are associated with worse outcomes.",
      "difficulty": "hard",
      "tags": [
        "PTSD",
        "symptom clusters",
        "evidence-based treatment"
      ]
    },
    {
      "type": "highlight",
      "id": "d3-tds-019",
      "stem": "Highlight ALL DSM-5 Criterion A trauma requirements for PTSD diagnosis.",
      "passage": "The patient was exposed to actual death when he witnessed his friend killed by an IED explosion. He experienced actual serious injury when he was wounded in the same attack. He was exposed to threatened death when the convoy came under fire. He was exposed to threatened serious injury when mortars landed near his position. He learned that his brother was killed in action, representing learning of violent death of a close family member. He experiences intrusive memories that are very distressing. As a combat medic, he had repeated exposure to aversive details of traumatic events. He also reports feeling sad and having difficulty concentrating since returning home.",
      "correctHighlights": [
        "exposed to actual death when he witnessed his friend killed",
        "experienced actual serious injury when he was wounded",
        "exposed to threatened death when the convoy came under fire",
        "exposed to threatened serious injury when mortars landed near his position",
        "learning of violent death of a close family member",
        "repeated exposure to aversive details of traumatic events"
      ],
      "explanation": "PTSD Criterion A requires: exposure to actual or threatened death, serious injury, or sexual violence through (1) directly experiencing, (2) witnessing in person, (3) learning it occurred to close family/friend (must be violent or accidental), or (4) repeated extreme exposure to aversive details (first responders). Intrusive memories, sadness, and concentration problems are PTSD symptoms but not Criterion A events.",
      "difficulty": "hard",
      "tags": [
        "PTSD",
        "Criterion A",
        "traumatic events"
      ]
    },
    {
      "type": "drag-drop-ordered",
      "id": "d3-tds-021",
      "stem": "Arrange the phases of trauma treatment according to the consensus phase-oriented model.",
      "options": [
        "Integration and rehabilitation (building healthy life)",
        "Stabilization and safety (establishing coping and grounding)",
        "Trauma processing and mourning (working through traumatic memories)",
        "Initial assessment and alliance building",
        "Termination and maintenance planning"
      ],
      "correctOrder": [
        3,
        1,
        2,
        0,
        4
      ],
      "explanation": "Phase-oriented trauma treatment: (1) Assessment and alliance, (2) Stabilization/safety—establishing affect regulation, grounding skills, safety, (3) Trauma processing—working through memories when stable (PE, CPT, EMDR), (4) Integration/rehabilitation—building healthy life, reconnecting, (5) Termination—maintaining gains. Skipping to trauma processing without stabilization risks destabilization.",
      "difficulty": "hard",
      "tags": [
        "phase-oriented treatment",
        "trauma treatment",
        "treatment phases"
      ]
    },
    {
      "type": "drag-drop-ordered",
      "id": "d3-tds-022",
      "stem": "Arrange the steps of Prolonged Exposure therapy for PTSD in the correct order.",
      "options": [
        "Psychoeducation about PTSD and treatment rationale",
        "Breathing retraining for anxiety management",
        "In-vivo exposure to avoided situations (hierarchical)",
        "Imaginal exposure to trauma memory with processing",
        "Final session review and relapse prevention"
      ],
      "correctOrder": [
        0,
        1,
        2,
        3,
        4
      ],
      "explanation": "PE protocol (typically 8-15 sessions): (1) Psychoeducation about PTSD and PE rationale, (2) Breathing retraining, (3) In-vivo exposure begins (gradually approaching avoided situations), (4) Imaginal exposure introduced (revisiting trauma memory aloud, repeatedly, with processing discussion), (5) Final sessions review progress and prevent relapse. In-vivo continues throughout; imaginal is core component.",
      "difficulty": "hard",
      "tags": [
        "Prolonged Exposure",
        "PTSD treatment",
        "treatment protocol"
      ]
    },
    {
      "type": "trend-analysis",
      "id": "d3-tds-023",
      "stem": "A patient with PTSD receiving Prolonged Exposure has PCL-5 scores (PTSD Checklist, higher = more symptoms) tracked across treatment:\n\nSession 1: 62\nSession 4: 58\nSession 7: 45\nSession 10: 32\nSession 13: 18\n\nClinically significant change threshold is typically >10 points. What does this pattern indicate?",
      "trendData": {
        "labels": [
          "Session 1",
          "Session 4",
          "Session 7",
          "Session 10",
          "Session 13"
        ],
        "values": [
          62,
          58,
          45,
          32,
          18
        ]
      },
      "options": [
        "Treatment failure due to initial minimal change",
        "Clinically significant improvement with good PE response trajectory",
        "Symptom exacerbation requiring treatment discontinuation",
        "Normal fluctuation without meaningful improvement"
      ],
      "correctAnswer": 1,
      "explanation": "This shows excellent PE response: PCL-5 dropped from 62 to 18 (44-point reduction). The pattern is typical—modest early change (during psychoeducation/breathing phases), then accelerating improvement as exposure components take effect. Final score of 18 is below diagnostic threshold for PTSD (typically 31-33). This represents remission.",
      "difficulty": "hard",
      "tags": [
        "Prolonged Exposure",
        "PCL-5",
        "treatment outcome"
      ]
    },
    {
      "type": "trend-analysis",
      "id": "d3-tds-024",
      "stem": "A patient receiving Cognitive Processing Therapy for PTSD has daily Practice Assignment ratings of belief in stuck point 'I am worthless because I couldn't prevent the assault' tracked (0-100% belief):\n\nWeek 1: 95%\nWeek 2: 90%\nWeek 3: 75%\nWeek 4: 50%\nWeek 5: 30%\nWeek 6: 15%\n\nWhat does this cognitive shift indicate?",
      "trendData": {
        "labels": [
          "Week 1",
          "Week 2",
          "Week 3",
          "Week 4",
          "Week 5",
          "Week 6"
        ],
        "values": [
          95,
          90,
          75,
          50,
          30,
          15
        ]
      },
      "options": [
        "Superficial compliance without genuine cognitive change",
        "Successful identification and restructuring of trauma-related stuck point",
        "Avoidance of trauma processing through intellectualization",
        "Premature cognitive change requiring stabilization"
      ],
      "correctAnswer": 1,
      "explanation": "This shows successful CPT: systematic reduction in maladaptive trauma-related belief. Stuck points are trauma-related cognitions that 'stuck' in extreme form. The gradual decrease (not sudden) suggests genuine restructuring through Socratic questioning and challenging evidence worksheets. Final low belief (15%) indicates accommodation of trauma without distorted self-blame.",
      "difficulty": "hard",
      "tags": [
        "Cognitive Processing Therapy",
        "stuck points",
        "cognitive restructuring"
      ]
    },
    {
      "type": "drag-drop-categorize",
      "id": "d3-tds-025",
      "stem": "Categorize each symptom according to whether it belongs to PTSD Cluster D (Negative alterations in cognitions and mood) or Cluster E (Alterations in arousal and reactivity).",
      "categories": [
        "Cluster D (Cognitions/Mood)",
        "Cluster E (Arousal/Reactivity)"
      ],
      "items": [
        "Persistent negative beliefs about self, others, or world",
        "Hypervigilance",
        "Markedly diminished interest in activities",
        "Exaggerated startle response",
        "Persistent inability to experience positive emotions",
        "Sleep disturbance"
      ],
      "correctCategorization": {
        "Cluster D (Cognitions/Mood)": [
          "Persistent negative beliefs about self, others, or world",
          "Markedly diminished interest in activities",
          "Persistent inability to experience positive emotions"
        ],
        "Cluster E (Arousal/Reactivity)": [
          "Hypervigilance",
          "Exaggerated startle response",
          "Sleep disturbance"
        ]
      },
      "explanation": "Cluster D (cognitive/mood): negative beliefs, distorted blame, negative emotional state, diminished interest, detachment, inability to feel positive emotions. Cluster E (arousal/reactivity): irritability/anger, reckless/self-destructive behavior, hypervigilance, startle, concentration problems, sleep disturbance. D reflects meaning/emotion changes; E reflects physiological dysregulation.",
      "difficulty": "hard",
      "tags": [
        "PTSD clusters",
        "DSM-5",
        "symptom classification"
      ]
    }
  ]
}
